Source: Progress in Neuro-Psychopharmacology and Biological Psychiatry. Unidades: FMRP, FORP
Subjects: CANABINOIDES, DOR FACIAL, NERVO TRIGÊMEO, QUALIDADE DE VIDA, FISIOPATOLOGIA, SISTEMA NERVOSO CENTRAL
ABNT
ESCOBAR-ESPINAL, Daniela Maria et al. Cannabidiol and it fluorinate analog PECS-101 reduces hyperalgesia and allodynia in trigeminal neuralgia via TRPV1 receptors. Progress in Neuro-Psychopharmacology and Biological Psychiatry, v. 132, p. 1-12, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.pnpbp.2024.110996. Acesso em: 29 abr. 2026.APA
Escobar-Espinal, D. M., Estela, A. N. V., Silva, N. B. P. da, Pereira, M. dos S., Guimarães, F. S., Del Bel, E. A., & Nascimento, G. C. do. (2024). Cannabidiol and it fluorinate analog PECS-101 reduces hyperalgesia and allodynia in trigeminal neuralgia via TRPV1 receptors. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 132, 1-12. doi:10.1016/j.pnpbp.2024.110996NLM
Escobar-Espinal DM, Estela ANV, Silva NBP da, Pereira M dos S, Guimarães FS, Del Bel EA, Nascimento GC do. Cannabidiol and it fluorinate analog PECS-101 reduces hyperalgesia and allodynia in trigeminal neuralgia via TRPV1 receptors [Internet]. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2024 ; 132 1-12.[citado 2026 abr. 29 ] Available from: https://doi.org/10.1016/j.pnpbp.2024.110996Vancouver
Escobar-Espinal DM, Estela ANV, Silva NBP da, Pereira M dos S, Guimarães FS, Del Bel EA, Nascimento GC do. Cannabidiol and it fluorinate analog PECS-101 reduces hyperalgesia and allodynia in trigeminal neuralgia via TRPV1 receptors [Internet]. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2024 ; 132 1-12.[citado 2026 abr. 29 ] Available from: https://doi.org/10.1016/j.pnpbp.2024.110996
